1. Home
  2. CATO vs MURA Comparison

CATO vs MURA Comparison

Compare CATO & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATO
  • MURA
  • Stock Information
  • Founded
  • CATO 1946
  • MURA 2013
  • Country
  • CATO United States
  • MURA Ireland
  • Employees
  • CATO N/A
  • MURA N/A
  • Industry
  • CATO Clothing/Shoe/Accessory Stores
  • MURA
  • Sector
  • CATO Consumer Discretionary
  • MURA
  • Exchange
  • CATO Nasdaq
  • MURA Nasdaq
  • Market Cap
  • CATO 70.0M
  • MURA 57.2M
  • IPO Year
  • CATO N/A
  • MURA N/A
  • Fundamental
  • Price
  • CATO $3.92
  • MURA $3.18
  • Analyst Decision
  • CATO
  • MURA Strong Buy
  • Analyst Count
  • CATO 0
  • MURA 4
  • Target Price
  • CATO N/A
  • MURA $16.00
  • AVG Volume (30 Days)
  • CATO 270.1K
  • MURA 178.6K
  • Earning Date
  • CATO 11-21-2024
  • MURA 11-13-2024
  • Dividend Yield
  • CATO 17.62%
  • MURA N/A
  • EPS Growth
  • CATO N/A
  • MURA N/A
  • EPS
  • CATO N/A
  • MURA N/A
  • Revenue
  • CATO $666,779,000.00
  • MURA N/A
  • Revenue This Year
  • CATO N/A
  • MURA N/A
  • Revenue Next Year
  • CATO N/A
  • MURA N/A
  • P/E Ratio
  • CATO N/A
  • MURA N/A
  • Revenue Growth
  • CATO N/A
  • MURA N/A
  • 52 Week Low
  • CATO $3.02
  • MURA $2.87
  • 52 Week High
  • CATO $7.80
  • MURA $6.25
  • Technical
  • Relative Strength Index (RSI)
  • CATO 47.48
  • MURA 35.65
  • Support Level
  • CATO $3.70
  • MURA $2.87
  • Resistance Level
  • CATO $4.29
  • MURA $4.20
  • Average True Range (ATR)
  • CATO 0.30
  • MURA 0.28
  • MACD
  • CATO 0.14
  • MURA -0.07
  • Stochastic Oscillator
  • CATO 70.16
  • MURA 23.66

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: